From the ∗Perelman School of Medicine at the University of Pennsylvania
†Department of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania
‡Department of Rheumatology, Penn Presbyterian Medical Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
§Francis I. Proctor Foundation
∥Department of Ophthalmology, University of California San Francisco, San Francisco, CA.
K.Y. is affiliated with the Chinese American Medical Society Summer Research Fellowship. G.S.Y. is supported by NIH National Eye Institute R01 EY026972 and Vision Research Core grant P30-EY01583-26. F.B.V. is a consultant and/or participant in clinical trials for Trinity Biotech, Biogen-Idec, and Novartis. J.A.G. is supported by NIH National Eye Institute K23 EY026998. M.M.G. is a consultant for Dompe and Lynthera, stock ownership/options for PRN. V.Y.B. is supported by National Eye Institute R01 EY026972; Research to Prevent Blindness; research grant from Bausch & Lomb; patents: EP 3210201, US 10,360,819, and US 10,783,505.
Data availability: The data and specimens used in this article were obtained from the Sjögren's International Collaborative Clinical Alliance (SICCA) Biorepository, funded under contract #HHSN26S201300057C by the National Institute of Dental and Craniofacial Research. This article was prepared using a publicly available SICCA data set and does not necessarily reflect the opinions or views of all SICCA investigators or the National Institute of Dental and Craniofacial Research.
Correspondence: Vatinee Y. Bunya, MD, MSCE, Department of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, 51 N 39th S, Philadelphia, PA 19104. E-mail: [email protected].
Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal’s Web site (www.jclinrheum.com).
